Patients with SSc who have gastric dysmotility present with a more severe disease phenotype and are associated with an increased risk for adverse outcomes.

Shayla Talei's inability to eat without pain caused her to lose about 100 lbs. over the course of months before she was ...

Patients taking a glucagon-like peptide 1 receptor agonist (GLP-1 RA) experience only a modest delay in gastric emptying of solid foods and no significant delay for liquids compared with those ...

A new $3.2 million National Institutes of Health (NIH) R01 grant is helping University of Nevada, Reno School of Medicine (UNR Med) researchers delve into one of the body’s most fascinating processes ...

TikToker Shayla Talei is setting the record straight about her stomach condition. The influencer, 31, who has been diagnosed ...

Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, according to new data on the real-world use of the drugs. At least three ...

Differing professional viewpoints, a lack of diagnostic standards, and regulatory roadblocks to new medications are among the factors hindering progress in treating people with gastroparesis, but ...